| Heading: |
Blood Cancer: Medical Treatments |
| Question ID: |
1758078 |
| UIN: |
HL4313 |
| House: |
Lords |
| Date tabled: |
2025-01-22 |
| Asking Member ID: |
4286 |
| Asking Member display name: |
Lord Mendelsohn
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Lord Mendelsohn
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what steps they are taking to ensure haemato-oncology services have the capacity to plan and adopt new innovations in the treatment of blood cancer. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-01-30 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Disease Registration Service, through the National Cancer Registration and Analysis Services, collects information on how many people in England have blood cancer, labelled as haematological neoplasms. This data supports service provision and... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |